Platinum Investment Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-830
Closed -$65.9K 99
2025
Q4
$65.9K Sell
830
-3,140
-79% -$248K 0.02% 107
2025
Q3
$299K Sell
3,970
-321
-7% -$22K 0.02% 98
2025
Q2
$296K Hold
4,291
0.02% 90
2025
Q1
$291K Buy
4,291
+2,311
+117% +$138K 0.02% 95
2024
Q4
$88.9K Buy
+1,980
New +$111K 0.01% 91
2022
Q1
Sell
-1,311
Closed -$135K 143
2021
Q4
$135K Sell
1,311
-198
-13% -$18.3K ﹤0.01% 127
2021
Q3
$128K Buy
+1,509
New +$126K ﹤0.01% 130

Other funds holding CVS

Platinum Investment Management's CVS Position: Q1 2026 in Review

Platinum Investment Management sold out of CVS Health (CVS) in Q1 2026, closing a stake of 830 shares — an estimated $65.9K sold.

Platinum Investment Management first reported a position in CVS in Q3 2021 and held it in 7 quarters. The position peaked at $299K in Q3 2025. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Platinum Investment Management reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
  • Platinum Investment Management sold 830 CVS Health shares in Q1 2026, an estimated $65.9K.
  • Platinum Investment Management first reported a position in CVS Health in Q3 2021 and held it in 7 quarters.
  • Platinum Investment Management's CVS Health position peaked at $299K in Q3 2025.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Platinum Investment Management's 13F filing for Q1 2026, filed 14 May 2026.